Healthcare costs are rising—and margins are shrinking.
In 2025, health plans, TPAs, MSOs, and provider organizations are facing new financial headwinds.
Industry forecasts project healthcare cost trends to rise 7–8%, with employers bracing for spikes in pharmacy spending. Meanwhile, the Medicare Physician Fee Schedule was cut by 2.83%, putting further pressure on providers managing fee-for-service revenue.
Amid this, rebate strategy is emerging as a critical but often overlooked financial lever—especially for risk-bearing entities covering physician-administered drugs.
Here’s what’s getting in the way:
- Manufacturer requirements are complex and constantly evolving
- Internal teams are understaffed or lack the tooling to manage quarterly submissions
- Rebate compliance requires precision—and the cost of disqualification is high
VativoRx helps organizations unlock value from medical rebate programs without adding internal burden.
- We provide preliminary opportunity assessments without PHI
- We request only minimum necessary PHI during onboarding, in line with HIPAA
- We manage the mapping, submissions, and compliance checks
- Your team stays focused—we handle the rebate lifecycle
In a year where CFOs and leadership teams are being asked to do more with less, rebate recovery shouldn’t be an afterthought. It’s a strategic lever that can make a difference.
Subscribe on LinkedIn to The Rebate Report for more insights, or connect with us directly to explore what your rebate opportunity could look like.
Sources:
